AnatolyDritschiloMDFACR
Radiation Oncology • Washington, DCBreast Cancer, Head & Neck, Skin Cancer
Professor of Medicine, Georgetown University
Dr. Dritschilo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3800 Reservoir Rd Nw
Washington, DC 20007Phone+1 202-444-3320
Education & Training
Tufts Medical CenterResidency, Radiation Oncology, 1977 - 1977
Brigham and Women's Hospital/Joint Center for Radiation TherapyResidency, Radiation Oncology, 1974 - 1977
University of Cincinnati Medical Center Inc.Internship, Transitional Year, 1973 - 1974
Rutgers New Jersey Medical SchoolClass of 1973
Certifications & Licensure
DC State Medical License 1979 - 2024
MD State Medical License 1980 - 2024
VA State Medical License 1997 - 2018- American Board of Radiology Therapeutic Radiology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Top Doctors:Washington DC Area Castle Connolly, 2012
- Join now to see all
Clinical Trials
- Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced Malignancies Start of enrollment: 2001 Mar 01
Publications & Presentations
PubMed
- 19 citationsProctitis following stereotactic body radiation therapy for prostate cancerDaniel Y. Joh, Leonard N. Chen, Gerald Porter, Aditi Bhagat, Sumit Sood
Radiation Oncology. 2014-12-12 - 161 citationsMulti-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancerFlorent Mouliere, Safia El Messaoudi, Dalong Pang, Anatoly Dritschilo, Alain R. Thierry
Molecular Oncology. 2014-07-01 - 7 citationsSignificant disparity in base and sugar damage in DNA resulting from neutron and electron irradiation.Dalong Pang, Jeffrey S. Nico, Lisa R. Karam, Olga A. Timofeeva, William F. Blakely
Journal of Radiation Research. 2014-11-01
Press Mentions
Shuttle Pharmaceuticals Holdings, Inc. Finalizes Agreements for Phase 2 Clinical Trial Enrollment: Press Release AnalysisOctober 30th, 2024- Shuttle Pharmaceuticals Provides First Quarter 2023 Corporate UpdateMay 26th, 2023
- Shuttle Pharmaceuticals Enters Research Agreement with Georgetown University for Testing of Small Molecule Radiation Sensitizers and Immune Activation CandidatesMarch 22nd, 2023
- Join now to see all
Grant Support
- Mechanisms Of Cellular Responses To Ionizing RadiationNational Cancer Institute1997–2006
- Cancer Center Support GrantNational Cancer Institute2005
- Georgetown University AP4 Center PLANNational Cancer Institute2004
- Radiosensitization Of Pancreatic Cancers Through RAF-1National Cancer Institute2002
- Molecular Studies Of Radiation Resistant Tumor CellsNational Cancer Institute1997–2001
- ATM Gene In Breast Cancer--Prospective Clinical TrialNational Cancer Institute1997–2001
- Molecular Studies Of Radiation Resistant Tumor CellsNational Cancer Institute1987–2000
- Oligonucleotide Manipulation--Tumor Cell RadioresistanceNational Cancer Institute1994
- Radiation Resistance And Adp-Ribose MetabolismNational Cancer Institute1992–1994
- Molecular Basis Of Tumor Resistance To Ionize RadiationNational Cancer Institute1990–1992
- Characterization Of Differential Gene Expression In Resistant CellsNational Cancer Institute1990–1992
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
